GENE ONLINE|News &
Opinion
Blog

Orphan Drug Designation
The U.S. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of DMD
2023-08-17
South Korea Puts Everest Medicines’ Nefecon On Fast Track
2023-02-10
Algernon Wins FDA Orphan Drug Designation For Rare Lung Disease Candidate
2022-12-07
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
BioCryst’s ALK-2 Inhibitor Granted FDA Orphan Drug Status For Rare Bone Disease
2022-09-01
Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers
2022-06-20
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
2022-03-29
GC Pharma’s Enzyme Replacement Therapy Wins Orphan Drug Designation from EMA
2021-11-02
R&D
BARDA Funds Development of Live Biotherapeutic Product Against C. difficile Infections
2020-10-05
Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
2020-03-25
Gilead’s Remdesivir Wins FDA’s Orphan Drug Designation for COVID-19 Treatment
2020-03-24
Pfizer Collaborates with Vivet to Develop Gene Therapy for Wilson Disease
2019-03-29
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top